Xanthomonas maltophilia produces two inducible β-lactamases, L-1 and L-2, and resists the antimicrobial activity of β-lactam antibiotics including carbapenems. L-1 has carbapenemase activity and L-2 is a cephalosporinase. It has been suggested that these β-lactamases share regulatory components. We isolated a recent clinical X. maltophilia strain susceptible to carbapenems and resistant to almost all the other β-lactam antibiotics tested. β-Lactamase induction with cefotaxime showed that the clinical isolate had low-level expression of L-1 β-lactamase but remained inducible for L-2 enzyme. The possible relationship of this enzyme to carbapenem sensitivity is considered.

Clinical isolate of a Xanthomonas maltophilia strain producing L-1-deficient and L-2-inducible β-lactamases

Stefani, S.;
1995-01-01

Abstract

Xanthomonas maltophilia produces two inducible β-lactamases, L-1 and L-2, and resists the antimicrobial activity of β-lactam antibiotics including carbapenems. L-1 has carbapenemase activity and L-2 is a cephalosporinase. It has been suggested that these β-lactamases share regulatory components. We isolated a recent clinical X. maltophilia strain susceptible to carbapenems and resistant to almost all the other β-lactam antibiotics tested. β-Lactamase induction with cefotaxime showed that the clinical isolate had low-level expression of L-1 β-lactamase but remained inducible for L-2 enzyme. The possible relationship of this enzyme to carbapenem sensitivity is considered.
1995
β-Lactamase; Carbapenemase; Xanthomonas maltophilia; Pharmacology (medical)
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/335185
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? ND
social impact